XBiotech Publishes Positive Results For Xilonix™ In Non-Small Cell Lung Cancer
Lung Cancer, News
The developer of True Human™ therapeutic antibodies, XBiotech Inc. recently announced the results of a clinical trial for non-small cell lung cancer (NSCLC) in which patients were treated with the Company’s lead True Human antibody, Xilonix™. The ... Read more